Bristol-Myers Lung-Cancer Drug Disappoints in Trial Analysis

·

·

Bristol-Myers Lung-Cancer Drug Disappoints in Trial Analysis

Sam Fazeli, an analyst with Bloomberg Intelligence, said Bristol-Myers shouldn't be written off just yet. “No one believes that Opdivo is dead in first line
See Original Article

Mexican Peso Jumps Before Debate as Asian Futures Tip Mixed Open

The yen weakened for the ninth time in 10 days after Bank of Japan chief Haruhiko Kuroda told Bloomberg News he can lower rates if needed to
See Original Article

Injured UKIP Legislator Discharged From French Hospital

London (AP) — A U.K. Independence Party legislator was discharged from a French hospital on Sunday following an altercation with another senior
See Original Article

Qatar University, Qatar Financial Center sign MoU with four major accounting firms for tax training …

Qatar University College of Business and Economics (QU-CBE) and Qatar Financial Center (QFC) Authority recently signed a Memorandum of
See Original Article

Accountants seek reassurance on IFRS 16 implementation

Discussing the most prevalent implementation issues that have arisen in the first 10 months of the IFRS 16 implementation period, Brian O'Donovan,
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.